Daniel William Rea
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
- PARP inhibition in cancer therapy
Papers in
-
- Breast Cancer Treatment Studies 51
- Oncology 13
- HER2/EGFR in Cancer Research 6
- Co-authors
- Caroline Seynaeve (18 shared papers)Christos J. Markopoulos (20 shared papers)Annette Hasenburg (20 shared papers)John M.S. Bartlett (22 shared papers)Lucinda Jane Billingham (4 shared papers)Cornelis J.�H. van de Velde (18 shared papers)Hein Putter (12 shared papers)E.T.M. Hille (6 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)The Lancet (7 papers)The Lancet Oncology (7 papers)The Breast (4 papers)European Journal of Cancer (4 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Daniel William Rea
102 papers receiving 6.5k citations
Daniel William Rea's Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 2.2k
- Oncology 1.2k
- Internal Medicine 107
- Drug Discovery 1
- Pulmonary and Respiratory Medicine 366
Countries citing papers authored by Daniel William Rea
This map shows the geographic impact of Daniel William Rea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel William Rea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel William Rea more than expected).
Fields of papers citing papers by Daniel William Rea
This network shows the impact of papers produced by Daniel William Rea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel William Rea. The network helps show where Daniel William Rea may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel William Rea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 416 | |
| 2 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 3 | 2005 | 321 | |
| 4 | 2019 | 318 | |
| 5 | 2011 | 302 | |
| 6 | 2020 | 300 | |
| 7 | 2015 | 299 | |
| 8 | 2021 | 248 | |
| 9 | 2019 | 225 | |
| 10 | 2019 | 223 | |
| 11 | Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials Hit paper breakdown → | 2022 | 203 |
| 12 | 2022 | 182 | |
| 13 | 2012 | 174 | |
| 14 | 2016 | 165 | |
| 15 | 2006 | 157 | |
| 16 | 2011 | 154 | |
| 17 | 2016 | 140 | |
| 18 | 2023 | 134 | |
| 19 | 2009 | 123 | |
| 20 | 2015 | 114 |
About Daniel William Rea
Daniel William Rea is a scholar working on Cancer Research, Oncology, Internal Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 103 papers that have together received 6.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (51 papers), HER2/EGFR in Cancer Research (6 papers), Metabolism, Diabetes, and Cancer (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Ethics in Clinical Research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (1.2k citations), Internal Medicine (107 citations), Drug Discovery (1 citation) and Pulmonary and Respiratory Medicine (366 citations). Daniel William Rea has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Caroline Seynaeve, Christos J. Markopoulos, Annette Hasenburg, John M.S. Bartlett, Lucinda Jane Billingham, Cornelis J.�H. van de Velde, Hein Putter, E.T.M. Hille, Dirk Kieback and Johan W.R. Nortier. Their work appears in journals such as Journal of Clinical Oncology, The Lancet, The Lancet Oncology, The Breast and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.